Efficacy, renal safety and tolerability of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in elderly patients with type 2 diabetes: A real-world experience
• Older patients with T2DM are often excluded from randomized controlled trials. • The insulin-independent mechanism of action makes SGLT2i suitable in the elderly. • Our study focused on SGLT2i-treated older patients with T2DM, stratified by age (65–69 and ≥70 years). • HbA1c reduction, eGFR variat...
Ausführliche Beschreibung
Bibliographische Detailangaben
Veröffentlicht in: | A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients. - 2016. - Amsterdam [u.a.]
|
1. Verfasser: |
Tumminia, Andrea
(VerfasserIn) |
Weitere Verfasser: |
Graziano, Marco
(BerichterstatterIn),
Vinciguerra, Federica
(BerichterstatterIn),
Lomonaco, Andrea
(BerichterstatterIn),
Frittita, Lucia
(BerichterstatterIn) |
Format: | Online-Aufsatz
|
Sprache: | English |
Veröffentlicht: |
2021
|
Zugriff auf das übergeordnete Werk: | A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients
|
Schlagworte: | Type 2 diabetes
Elderly
Sodium-glucose cotransporter 2 inhibitors
Real-world evidence |
Umfang: | 6 |